Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples